1, so we have an ongoing pII study on T817MA conne
Post# of 30027
Posted On: 02/15/2015 9:01:23 PM
.jpg)
1, so we have an ongoing pII study on T817MA connected to Stern, fully funded by Toyoma, thats having problems getting good data, getting patients to finish trials, using imaging etc. approx 400 people in this trial, with numerous sub study add ons
2. and the we have the huge A4 study starting soon, run by Stern and others, fully funded by Eli Lilly ( where we got Dr. Trzepacz from), the NIH (JC), and philanthropies. http://www.bu.edu/alzresearch/ http://www.amarantus.com/about/alzheimers-dis...ostics-sab
10,000 individuals needed in US Canada and AUS for 1,000 to be enrolled in study =$$$ on screening and $$$ on continual evaluation for the MONTHLY infusions. 10,000x $1,000 = $10mill. 1,000 x let's say quarterly x4 x $1,000. This has got to be in the revenue range of $10-20mill plus. This trial gives monthly infusions for 3.5 years, records evaluations from an observer/friend once a week, and could be huge if we get in on it. I went through the screening questions, and "Are you willing to have your health monitored throughout the study with the following assessments?...e. Blood and urine tests" is a question, though admittedly that's likely just to make sure the infusions are killing you. http://a4study.org/screener/
if solanezumab is succesfful and Lympro is involved, it will become one of, or the paired diagnostic. $$$
http://a4study.org/about/
please note, Dr. Stern has an "exciting" presentation February 24 Alzheimer's Disease & Dementia 2015: Reasons for Hope
2. and the we have the huge A4 study starting soon, run by Stern and others, fully funded by Eli Lilly ( where we got Dr. Trzepacz from), the NIH (JC), and philanthropies. http://www.bu.edu/alzresearch/ http://www.amarantus.com/about/alzheimers-dis...ostics-sab
10,000 individuals needed in US Canada and AUS for 1,000 to be enrolled in study =$$$ on screening and $$$ on continual evaluation for the MONTHLY infusions. 10,000x $1,000 = $10mill. 1,000 x let's say quarterly x4 x $1,000. This has got to be in the revenue range of $10-20mill plus. This trial gives monthly infusions for 3.5 years, records evaluations from an observer/friend once a week, and could be huge if we get in on it. I went through the screening questions, and "Are you willing to have your health monitored throughout the study with the following assessments?...e. Blood and urine tests" is a question, though admittedly that's likely just to make sure the infusions are killing you. http://a4study.org/screener/
if solanezumab is succesfful and Lympro is involved, it will become one of, or the paired diagnostic. $$$
http://a4study.org/about/
please note, Dr. Stern has an "exciting" presentation February 24 Alzheimer's Disease & Dementia 2015: Reasons for Hope
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼